Primary Gene Identifiers
| Database | Identifier | Description |
|---|
| HGNC | HGNC:795 | ATM serine/threonine kinase |
| Symbol | ATM | Approved symbol |
| Ensembl | ENSG00000149311 | Human gene ID |
| NCBI Entrez | 472 | Gene ID |
| OMIM | 607585 | Gene/locus ID |
Genomic Location
| Attribute | Value |
|---|
| Chromosome | 11 |
| Cytogenetic Band | 11q22.3 |
| Start Position | 108,222,804 |
| End Position | 108,369,102 |
| Strand | + (forward) |
| Gene Span | ~146.3 kb |
Gene Nomenclature
| - Approved Name | - Previous Names | - Previous Symbols | - Aliases | - Locus Type | - Gene Groups |
|---|
| ATM serine/threonine kinase | Ataxia telangiectasia mutated | ATA, ATDC, ATC, ATD | TEL1, TELO1 | Gene with protein product (protein-coding) | Armadillo like helical domain containing, Phosphatidylinositol 3-kinase-related kinase family, BRCA1-associated genome surveillance complex | |
| | | | | | Transcript Identifiers** |
Ensembl Transcripts
Total Transcripts: 64
| Transcript ID | Biotype | Start | End |
|---|
| ENST00000675843 | protein_coding | 108,223,067 | 108,369,102 |
| ENST00000601453 | protein_coding | 108,222,804 | 108,369,102 |
| ENST00000452508 | protein_coding | 108,222,823 | 108,369,102 |
| ENST00000278616 | protein_coding | 108,223,411 | 108,367,264 |
| ENST00000923922 | protein_coding | 108,223,080 | 108,369,102 |
| ENST00000971291 | protein_coding | 108,223,077 | 108,366,048 |
| ENST00000713844 | protein_coding | 108,223,120 | 108,365,723 |
| ENST00000531525 | protein_coding | 108,223,067 | 108,295,996 |
| ENST00000530958 | protein_coding | 108,223,103 | 108,236,534 |
| ENST00000684029 | protein_coding | 108,224,768 | 108,236,578 |
| ...and 54 more transcripts (retained_intron, NMD, protein_coding_CDS_not_defined) | | | |
Biotype Breakdown:
- Protein coding: 21 transcripts
- Retained intron: 18 transcripts
- Nonsense mediated decay: 10 transcripts
- Protein coding CDS not defined: 15 transcripts
RefSeq Transcripts (Human)
Total: 109 RefSeq entries
MANE Select (Canonical Clinical Standard):
| Accession | Type | Status |
|---|
| NM_000051 | mRNA | REVIEWED - MANE Select |
| NP_000042 | Protein | REVIEWED - MANE Select |
Additional Human RefSeq mRNAs:
| Accession | Status |
|---|
| NM_001351834 | REVIEWED |
| NM_001351835 | REVIEWED |
| NM_001351836 | REVIEWED |
CCDS IDs
| CCDS ID | Description |
|---|
| CCDS31669 | Consensus CDS |
| CCDS86245 | Consensus CDS |
Exons for Canonical Transcript (ENST00000675843)
Total Exon Count: 63
| Exon ID | Start | End | Strand |
|---|
| ENSE00004021474 | 108,223,067 | 108,223,186 | + |
| ENSE00003742933 | 108,227,595 | 108,227,696 | + |
| ENSE00003725082 | 108,227,776 | 108,227,888 | + |
| ENSE00003744805 | 108,229,178 | 108,229,323 | + |
| ENSE00003129472 | 108,235,670 | 108,235,834 | + |
| ENSE00004021469 | 108,243,953 | 108,244,118 | + |
| ENSE00004021454 | 108,244,788 | 108,245,026 | + |
| ENSE00004021457 | 108,246,964 | 108,247,127 | + |
| ENSE00004021473 | 108,248,933 | 108,249,102 | + |
| ENSE00004021493 | 108,250,701 | 108,251,072 | + |
| ...and 53 more exons | | | |
| ENSE00004021453 | 108,365,325 | 108,369,102 | + (terminal) |
Section 3: Protein Identifiers
UniProt Accessions
| Accession | Name | Status | Length | Mass |
|---|
| Q13315 | Serine-protein kinase ATM | Reviewed (Swiss-Prot) | 3,056 aa | 350,687 Da |
Alternative Names: Ataxia telangiectasia mutated
RefSeq Protein (Human)
| Accession | Status | Canonical |
|---|
| NP_000042 | REVIEWED | MANE Select |
| NP_001338763 | REVIEWED | - |
| NP_001338764 | REVIEWED | - |
| NP_001338765 | REVIEWED | - |
Protein Domains and Families
Total InterPro Annotations: 11
| InterPro ID | Name | Type |
|---|
| IPR000403 | PI3/4_kinase_cat_dom | Domain |
| IPR003151 | PIK-rel_kinase_FAT | Domain |
| IPR003152 | FATC_dom | Domain |
| IPR014009 | PIK_FAT | Domain |
| IPR021668 | TAN | Domain |
| IPR044107 | PIKKc_ATM | Domain |
| IPR018936 | PI3/4_kinase_CS | Conserved_site |
| IPR011009 | Kinase-like_dom_sf | Homologous_superfamily |
| IPR016024 | ARM-type_fold | Homologous_superfamily |
| IPR036940 | PI3/4_kinase_cat_sf | Homologous_superfamily |
| IPR038980 | ATM_plant | Family |
Section 4: Structure Identifiers
Experimental Structures
Total PDB Structures: 14
| PDB ID | Title | Method | Resolution |
|---|
| 7SIC | Human ATM Dimer | Cryo-EM | 2.51 Å |
| 7SID | Human ATM Dimer Bound to Nbs1 | Cryo-EM | 2.53 Å |
| 8OXQ | ATM(Q2971A) dimeric C-terminal in complex with Mg AMP-PNP | Cryo-EM | 2.5 Å |
| 8OXP | ATM(Q2971A) in complex with Mg AMP-PNP | Cryo-EM | 2.6 Å |
| 7NI5 | Human ATM kinase with bound inhibitor KU-55933 | Cryo-EM | 2.78 Å |
| 7NI6 | Human ATM kinase with bound ATPγS | Cryo-EM | 2.8 Å |
| 7NI4 | Human ATM kinase domain with bound M4076 inhibitor | Cryo-EM | 3.0 Å |
| 8OXO | ATM activated by oxidative stress with p53 peptide | Cryo-EM | 3.0 Å |
| 8OXM | ATM activated by oxidative stress with p53 peptide | Cryo-EM | 3.3 Å |
| 6K9L | Human dimeric ATM kinase | Cryo-EM | 4.27 Å |
| 5NP0 | Closed dimer of human ATM | Cryo-EM | 5.7 Å |
| 5NP1 | Open protomer of human ATM | Cryo-EM | 5.7 Å |
| 6K9K | Monomeric human ATM kinase | Cryo-EM | 7.82 Å |
| 6HKA | FATC domain of ATM | Solution NMR | - |
Predicted Structures
| Source | ID | Notes |
|---|
| AlphaFold | AF-Q13315-F1 | Full-length prediction available |
Section 5: Cross-Species Orthologs
Model Organism Orthologs
| Organism | Gene ID | Symbol | Biotype |
|---|
| Mouse (Mus musculus) | ENSMUSG00000034218 | Atm | protein_coding |
| Rat (Rattus norvegicus) | ENSRNOG00000029773 | Atm | protein_coding |
| Zebrafish (Danio rerio) | ENSDARG00000002385 | atm | protein_coding |
| Fruit fly (Drosophila) | No direct ortholog | - | - |
| Worm (C. elegans) | No direct ortholog | - | - |
| Yeast (S. cerevisiae) | TEL1 (functional analog) | - | - |
Human Paralogs (PIKK Family)
| Gene ID | Symbol | Description |
|---|
| ENSG00000175054 | ATR | ATR serine/threonine kinase |
| ENSG00000253729 | PRKDC | DNA-dependent protein kinase catalytic subunit |
| ENSG00000198793 | MTOR | Mechanistic target of rapamycin kinase |
| ENSG00000157106 | SMG1 | SMG1 nonsense mediated mRNA decay |
| ENSG00000196367 | TRRAP | Transformation/transcription domain associated protein |
Section 6: Clinical Variants & AI Predictions
ClinVar Variant Summary
Total Variants: 18,209
| Classification | Count (approximate) |
|---|
| Pathogenic | >500 |
| Likely Pathogenic | >300 |
| Uncertain Significance (VUS) | >10,000 |
| Likely Benign | >2,000 |
| Benign | >1,500 |
| Conflicting Classifications | >500 |
TOP 50 Pathogenic/Likely Pathogenic Variants
| Variant ID | HGVS Notation | Type | Condition |
|---|
| 1027442 | c.2152dup (p.Cys718fs) | Duplication | Frameshift |
| 1068534 | c.6242T>A (p.Leu2081Ter) | SNV | Nonsense |
| 1068785 | c.8785A>T (p.Arg2929Ter) | SNV | Nonsense |
| 1069197 | c.1179G>A (p.Trp393Ter) | SNV | Nonsense |
| 1069441 | c.1262C>G (p.Ser421Ter) | SNV | Nonsense |
| 1069650 | c.3145_3146del (p.Leu1049fs) | Deletion | Frameshift |
| 1069824 | c.4668T>A (p.Tyr1556Ter) | SNV | Nonsense |
| 1070072 | c.8923del (p.Glu2975fs) | Deletion | Frameshift |
| 1070576 | c.1078del (p.Asp360fs) | Deletion | Frameshift |
| 1070606 | c.5383_5384del (p.Trp1795fs) | Deletion | Frameshift |
| 1071816 | c.856C>T (p.Gln286Ter) | SNV | Nonsense |
| 1072054 | c.3188dup (p.Met1064fs) | Duplication | Frameshift |
| 1072739 | c.4093del (p.Leu1365fs) | Deletion | Frameshift |
| 1072740 | c.7705del (p.Asp2569fs) | Deletion | Frameshift |
| 1073216 | c.5293C>T (p.Gln1765Ter) | SNV | Nonsense |
| 1073457 | c.2464_2466+2del | Deletion | Splice |
| 1074091 | c.5677_5680del (p.Glu1894fs) | Deletion | Frameshift |
| 1074412 | c.900dup (p.Gly301fs) | Duplication | Frameshift |
| 1074638 | c.8690del (p.Gly2897fs) | Deletion | Frameshift |
| 1074652 | c.3546_3547del (p.Asn1183fs) | Deletion | Frameshift |
| 1074850 | c.3758_3759del (p.Lys1253fs) | Deletion | Frameshift |
| 1074976 | c.728dup (p.Leu243fs) | Duplication | Frameshift |
| 1075035 | c.1762del (p.Asp588fs) | Deletion | Frameshift |
| 1013733 | c.3248A>G (p.His1083Arg) | SNV | Missense - Pathogenic |
| 1067957 | c.1802+1G>T | SNV | Splice site |
| ...and many more | | | |
SpliceAI Predictions
Total Predicted Splice-Altering Variants: 11,573
TOP 50 High-Confidence Splice Variants (delta score ≥0.9):
| Variant | Effect | Delta Score |
|---|
| 11:108222864:GC:G | donor_gain | 0.98 |
| 11:108222865:C:CG | donor_gain | 0.98 |
| 11:108222865:C:G | donor_gain | 0.99 |
| 11:108223019:G:GT | donor_gain | 0.99 |
| 11:108222959:A:AG | donor_gain | 0.97 |
| 11:108222965:G:GT | donor_gain | 0.96 |
| 11:108223056:G:GT | donor_gain | 0.97 |
| 11:108223061:GGGA:G | donor_gain | 0.96 |
| 11:108223062:G:GT | donor_gain | 0.97 |
| 11:108223063:GAG:G | donor_gain | 0.97 |
| 11:108223065:G:GG | donor_gain | 0.98 |
| ...and more with scores >0.9 | | |
AlphaMissense Predictions
Total Missense Predictions: 20,248
TOP 50 Likely Pathogenic Missense Variants (score >0.9):
| Variant | Protein Change | Pathogenicity Score | Class |
|---|
| 11:108227647:T:C | L8P | 0.992 | likely_pathogenic |
| 11:108227872:T:A | W57R | 0.998 | likely_pathogenic |
| 11:108227872:T:C | W57R | 0.998 | likely_pathogenic |
| 11:108227874:G:C | W57C | 0.996 | likely_pathogenic |
| 11:108227874:G:T | W57C | 0.996 | likely_pathogenic |
| 11:108227831:T:C | L43P | 0.994 | likely_pathogenic |
| 11:108227692:G:C | R23P | 0.992 | likely_pathogenic |
| 11:108227873:G:C | W57S | 0.987 | likely_pathogenic |
| 11:108227792:T:C | F30S | 0.985 | likely_pathogenic |
| 11:108227831:T:A | L43Q | 0.980 | likely_pathogenic |
| 11:108227668:T:C | L15P | 0.978 | likely_pathogenic |
| 11:108227801:T:C | L33P | 0.978 | likely_pathogenic |
| 11:108227658:T:C | C12R | 0.972 | likely_pathogenic |
| 11:108227647:T:A | L8Q | 0.969 | likely_pathogenic |
| 11:108227833:G:C | D44H | 0.968 | likely_pathogenic |
| 11:108227873:G:T | W57L | 0.967 | likely_pathogenic |
| 11:108227831:T:G | L43R | 0.966 | likely_pathogenic |
| 11:108227872:T:G | W57G | 0.965 | likely_pathogenic |
| 11:108227647:T:G | L8R | 0.963 | likely_pathogenic |
| 11:108227660:C:G | C12W | 0.961 | likely_pathogenic |
| ...and more | | | |
Section 7: Biological Pathways & Gene Ontology
Reactome Pathways
Total Pathways: 61
| Pathway ID | Name | Disease Pathway |
|---|
| R-HSA-5693548 | Sensing of DNA Double Strand Breaks | No |
| R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation at DSBs | No |
| R-HSA-5693532 | DNA Double-Strand Break Repair | No |
| R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | No |
| R-HSA-5685942 | HDR through Homologous Recombination (HRR) | No |
| R-HSA-5685938 | HDR through Single Strand Annealing (SSA) | No |
| R-HSA-69473 | G2/M DNA damage checkpoint | No |
| R-HSA-69563 | p53-Dependent G1 DNA Damage Response | No |
| R-HSA-69541 | Stabilization of p53 | No |
| R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | No |
| R-HSA-3700989 | Transcriptional Regulation by TP53 | No |
| R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | No |
| R-HSA-912446 | Meiotic recombination | No |
| R-HSA-9664873 | Pexophagy | No |
| R-HSA-73894 | DNA Repair | No |
| R-HSA-1640170 | Cell Cycle | No |
| R-HSA-69620 | Cell Cycle Checkpoints | No |
| R-HSA-9675135 | Diseases of DNA repair | Yes |
| R-HSA-9675136 | Diseases of DNA Double-Strand Break Repair | Yes |
| R-HSA-9701192 | Defective HRR due to BRCA1 loss of function | Yes |
| ...and 41 more pathways | | |
Gene Ontology Annotations
Total GO Terms: 123
Biological Process (TOP 20)
| GO ID | Term |
|---|
| GO:0006302 | double-strand break repair |
| GO:0006281 | DNA repair |
| GO:0000077 | DNA damage checkpoint signaling |
| GO:0006974 | DNA damage response |
| GO:0042770 | signal transduction in response to DNA damage |
| GO:0030330 | DNA damage response, signal transduction by p53 class mediator |
| GO:0007095 | mitotic G2 DNA damage checkpoint signaling |
| GO:0000724 | double-strand break repair via homologous recombination |
| GO:0006303 | double-strand break repair via nonhomologous end joining |
| GO:0010212 | response to ionizing radiation |
| GO:0006468 | protein phosphorylation |
| GO:0046777 | protein autophosphorylation |
| GO:0000723 | telomere maintenance |
| GO:0006979 | response to oxidative stress |
| GO:0043065 | positive regulation of apoptotic process |
| GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0007131 | reciprocal meiotic recombination |
| GO:0051726 | regulation of cell cycle |
| GO:0033151 | V(D)J recombination |
| GO:0050821 | protein stabilization |
Molecular Function (TOP 20)
| GO ID | Term |
|---|
| GO:0004674 | protein serine/threonine kinase activity |
| GO:0004677 | DNA-dependent protein kinase activity |
| GO:0005524 | ATP binding |
| GO:0003677 | DNA binding |
| GO:0005515 | protein binding |
| GO:0016301 | kinase activity |
| GO:0016740 | transferase activity |
| GO:0016303 | 1-phosphatidylinositol-3-kinase activity |
| GO:0000166 | nucleotide binding |
| GO:0042802 | identical protein binding |
| GO:0044877 | protein-containing complex binding |
| GO:0035979 | histone H2AXS139 kinase activity |
Cellular Component (TOP 20)
| GO ID | Term |
|---|
| GO:0005634 | nucleus |
| GO:0005654 | nucleoplasm |
| GO:0005829 | cytosol |
| GO:0005737 | cytoplasm |
| GO:0005694 | chromosome |
| GO:0000781 | chromosome, telomeric region |
| GO:0035861 | site of double-strand break |
| GO:0005730 | nucleolus |
| GO:0005813 | centrosome |
| GO:0005819 | spindle |
| GO:0005777 | peroxisome |
| GO:0005782 | peroxisomal matrix |
| GO:0031410 | cytoplasmic vesicle |
| GO:0005856 | cytoskeleton |
Section 8: Protein Interactions & Molecular Networks
Protein-Protein Interactions
Total STRING Interactions: 6,446
Total IntAct Interactions: 264
Total BioGRID Interactions: 668
TOP 50 Highest-Confidence Interactors (STRING)
| UniProt ID | Gene | Confidence Score |
|---|
| O96017 | CHK2 | 999 |
| P38398 | BRCA1 | 999 |
| Q14676 | MDC1 | 997 |
| Q12888 | TP53BP1 | 996 |
| P43246 | MSH2 | 995 |
| Q8WXE1 | ATRIP | 995 |
| P52701 | MSH6 | 994 |
| P40692 | MLH1 | 992 |
| P16104 | H2AX | 984 |
| O14757 | CHK1 | 975 |
| P04637 | TP53 | 975 |
| P51587 | BRCA2 | 972 |
| Q9BXW9 | FANCD2 | 968 |
| P13010 | XRCC5 (Ku80) | 964 |
| O43313 | WRN | 961 |
| Q06609 | RAD51 | 958 |
| Q8N2W9 | PIH1D1 | 956 |
| Q00987 | MDM2 | 955 |
| Q9Y6K9 | NEMO | 949 |
| P49959 | MRE11 | 941 |
| O60934 | NBN (Nibrin) | 936 |
| Q92993 | KAT5 (TIP60) | 936 |
| P12956 | XRCC6 (Ku70) | 931 |
| O15297 | TDP2 | 924 |
| Q13547 | HDAC1 | 923 |
| ...and more | | |
Protein Similarity
ESM2 Structural/Embedding Similarity
Total Similar Proteins: 88
| UniProt | Top Similarity | Avg Similarity |
|---|
| Q17QT7 | 1.0000 | 0.9891 |
| Q2KJI3 | 1.0000 | 0.9894 |
| Q8BHZ0 | 1.0000 | 0.9890 |
| Q921M7 | 1.0000 | 0.9893 |
| Q9H0Q0 | 1.0000 | 0.9891 |
| Q9NUQ9 | 1.0000 | 0.9894 |
| Q8BKX6 (ATR) | 0.9999 | 0.9926 |
| Q96Q15 (SMG1) | 0.9999 | 0.9925 |
| P78527 (PRKDC) | 0.9994 | 0.9936 |
| Q62388 (Mouse Atm) | 0.9991 | 0.9926 |
DIAMOND Sequence Homology
Total Homologous Proteins: 30
| UniProt | Gene | Top Identity | Bitscore |
|---|
| Q8BKX6 | ATR | 97.7% | 6960 |
| Q96Q15 | SMG1 | 97.7% | 6960 |
| Q6PQD5 | Mouse Atm | 88.4% | 5360 |
| Q13315 | ATM (self) | 88.4% | 5370 |
| Q62388 | Mouse Atm | 83.8% | 5063 |
| C5J7W8 | - | 73.4% | 5246 |
| Q9DE14 | - | 72.6% | 3774 |
| P32600 | TEL1 (yeast) | 68.5% | 3249 |
| P35169 | SMG1 | 68.3% | 3269 |
Section 9: Transcription Factor Regulatory Data
Note: ATM is primarily a kinase, not a canonical transcription factor, but it regulates gene expression through phosphorylation of TFs.
Downstream Targets (Genes Regulated BY ATM Signaling)
Total Target Genes: 28 (CollecTRI database)
| Target Gene | Regulation Type |
|---|
| BAX | Activation |
| BCL2 | Repression |
| CDKN1A (p21) | Activation |
| E2F1 | Activation |
| FAS | Activation |
| FOXM1 | Activation |
| GADD45A | Activation |
| MCL1 | Activation |
| PCNA | Unknown |
| PMAIP1 (NOXA) | Repression |
| SP1 | Repression |
| TERF1 | Repression |
| TNFRSF10B (TRAIL-R2) | Repression |
| VEGFA | Repression |
| KLRK1 (NKG2D) | Activation |
| COL3A1 | Activation |
| DUSP1 | Activation |
| ...and more | |
Signaling Targets (SIGNOR Database)
Total Signaling Interactions: 277
Key Phosphorylation Targets:
| Target | Effect | Score |
|---|
| TP53 | Up-regulates (stabilization) | 0.84 |
| TP53BP1 | Phosphorylation | 0.87 |
| BRCA1 | Up-regulates | 0.82 |
| CHEK1 | Up-regulates | 0.84 |
| CHEK2 | Up-regulates | 0.87 |
| NBN | Binding | 0.86 |
| EXO1 | Up-regulates | 0.83 |
| RAD50 | Phosphorylation | 0.81 |
| RPA2 | Up-regulates | 0.81 |
| H2AFX (H2AX) | Up-regulates | 0.20 |
| MDM2 | Down-regulates | 0.76 |
| MDM4 | Down-regulates | 0.73 |
| SMC1A | Up-regulates | 0.70 |
| SMC3 | Phosphorylation | 0.74 |
Upstream Regulators (TFs that Regulate ATM)
Total: 25 regulators
| TF Gene | Regulation | Confidence |
|---|
| E2F1 | Activation | High |
| FOXO3 | Unknown | High |
| GRHL3 | - | High |
| NFAT5 | - | High |
| NR2C2 | - | High |
| TP63 | - | High |
| BRCA1 | Activation | - |
| MYC | Activation | - |
| BTF3 | Activation | - |
| TWIST1 | Activation | - |
| TWIST2 | Activation | - |
| E2F3 | Activation | Low |
| SP1 | Unknown | Low |
| AR | Unknown | - |
| RBBP8 | Activation | - |
| RBPJ | Activation | Low |
Section 10: Drug & Pharmacology Data
ChEMBL Target Information
| Target ID | Name | Type | Activity Count |
|---|
| CHEMBL3797 | Serine-protein kinase ATM | Single Protein | 3,924 |
| CHEMBL3885635 | ATM/ATR | Protein Family | - |
| CHEMBL6066129 | VHL/ATM | Protein-Protein Interaction | - |
Total Molecules Screened: 3,752
Targeting Molecules by Development Phase
Phase 4 (Approved Drugs with ATM Activity)
| ChEMBL ID | Name | Mechanism |
|---|
| CHEMBL1083993 | Amiodarone Hydrochloride | Multi-target |
| CHEMBL1103 | Furazolidone | Antibacterial |
| CHEMBL1200430 | Estradiol Acetate | Hormone |
| CHEMBL1200493 | Naftifine Hydrochloride | Antifungal |
| CHEMBL1200938 | Methysergide Maleate | Anti-migraine |
| CHEMBL1200964 | Amitriptyline Hydrochloride | Antidepressant |
| CHEMBL1409 | Fluvoxamine Maleate | SSRI |
| CHEMBL1511 | Estradiol Valerate | Hormone |
| CHEMBL1525 | Permethrin | Insecticide |
| CHEMBL1670 | Mitotane | Antineoplastic |
| CHEMBL1717 | Ticlopidine Hydrochloride | Antiplatelet |
| CHEMBL405110 | Methylene Blue | Multiple |
| CHEMBL421701 | Dithiazanine Iodide | Anthelmintic |
| CHEMBL456 | Ethacrynic Acid | Diuretic |
| CHEMBL498847 | Secnidazole | Antibiotic |
| CHEMBL590 | Menadione | Vitamin K3 |
| CHEMBL672 | Fenofibrate | Lipid lowering |
| CHEMBL932 | Dipyridamole | Antiplatelet |
Phase 3 Development
| ChEMBL ID | Name | Type |
|---|
| CHEMBL1879463 | Dactolisib | Small molecule (ATM/PI3K inhibitor) |
| CHEMBL249856 | Enoximone | Small molecule |
Phase 2 Development
| ChEMBL ID | Name | Type |
|---|
| CHEMBL3989870 | Berzosertib | ATR/ATM inhibitor |
| CHEMBL5314413 | Lartesertib | ATM inhibitor |
| CHEMBL11417 | Streptonigrin | Antitumor |
| CHEMBL1256686 | Calcimycin | Ionophore |
Known ATM Inhibitors (from SIGNOR)
| Compound | Effect |
|---|
| KU-60019 | Chemical inhibition |
| KU-55933 | Chemical inhibition |
| 2-(4-morpholinyl)-6-(1-thianthrenyl)-4-pyranone | Chemical inhibition |
Pharmacogenomics (PharmGKB)
| PharmGKB ID | Symbol | VIP Gene | CPIC Guideline |
|---|
| PA61 | ATM | Yes | No |
ATM is a Very Important Pharmacogene (VIP) due to its role in DNA damage response and cancer therapy.
Section 11: Expression Profiles
Overall Expression Pattern
| Attribute | Value |
|---|
| Expression Breadth | Ubiquitous |
| Total Present Calls | 286 |
| Max Expression Score | 97.33 |
TOP 30 Tissues by Expression Score (Bgee)
| Tissue | Expression Score | Rank |
|---|
| Calcaneal tendon | 97.33 | 1,250 |
| Colonic epithelium | 97.24 | 1,290 |
| Corpus callosum | 96.41 | 1,670 |
| Lymph node | 96.36 | 1,700 |
| Bone marrow cell | 96.26 | 1,750 |
| Body of pancreas | 95.70 | 2,010 |
| Adrenal tissue | 95.39 | 2,150 |
| Sural nerve | 95.28 | 2,200 |
| Tonsil | 95.10 | 2,290 |
| Tendon | 94.86 | 2,400 |
| Superficial temporal artery | 94.55 | 2,540 |
| Ventricular zone | 94.50 | 2,570 |
| Buccal mucosa cell | 94.38 | 2,620 |
| Leukocyte | 94.37 | 2,630 |
| Spleen | 94.31 | 2,650 |
| Monocyte | 94.26 | 2,680 |
| Mononuclear cell | 94.26 | 2,670 |
| Granulocyte | 94.24 | 2,680 |
| Left ovary | 93.84 | 2,870 |
| Male germ line stem cell (testis) | 93.75 | 2,910 |
| Right ovary | 93.70 | 2,940 |
| Pituitary gland | 93.10 | 3,220 |
| C1 cervical spinal cord | 93.01 | 3,260 |
| Nasopharynx epithelium | 92.81 | 3,350 |
| Trigeminal ganglion | 92.74 | 3,390 |
| Ganglionic eminence | 92.73 | 3,390 |
| Bone marrow | 92.60 | 3,450 |
| Blood | 92.52 | 3,490 |
| Vermiform appendix | 92.50 | 3,500 |
| Ovary | 92.48 | 3,510 |
Single-Cell Expression Datasets (Expression Atlas)
Total Datasets: 8
| Dataset ID | Description | Cells |
|---|
| E-HCAD-31 | Pancreatic islets cells (healthy & T2D) | 38,217 |
| E-MTAB-9221 | COVID-19 whole blood | 27,943 |
| E-MTAB-8911 | Chronic Graft-Versus-Host Disease | 19,075 |
| E-MTAB-11011 | B cells in COVID-19 | 15,100 |
| E-MTAB-9067 | Fetal liver/bone marrow haematopoiesis | 5,865 |
| E-CURD-97 | CD4+ Treg/Tmem cells | 1,677 |
| E-MTAB-7303 | iPSC-dopamine neurons (Parkinson's) | 123 |
| E-MTAB-6386 | PBMC-derived B cells | 117 |
Section 12: Disease Associations
Mendelian Disease Associations (GenCC)
Total Gene-Disease Associations: 11
| Disease | Classification | Inheritance | Evidence |
|---|
| Ataxia telangiectasia (OMIM:208900) | Definitive | Autosomal recessive | Multiple sources |
| Hereditary breast carcinoma (OMIM:114480) | Definitive | Autosomal dominant | Ambry Genetics |
| Prostate cancer (MONDO:0008315) | Moderate | Autosomal dominant | Ambry Genetics |
| Sarcoma (MONDO:0005089) | Moderate | Autosomal dominant | Genomics England |
| Hereditary nonpolyposis colon cancer | Limited | Autosomal dominant | Ambry Genetics |
| Gastric carcinoma (MONDO:0004950) | Limited | Autosomal dominant | Ambry Genetics |
Orphanet Disease Associations
Total: 8
| Orphanet ID | Disease Name | Type | Gene Count |
|---|
| 100 | Ataxia-telangiectasia | Disease | 1 |
| 370109 | Ataxia-telangiectasia variant | Disease | 1 |
| 145 | Hereditary breast and/or ovarian cancer syndrome | Disease | 15 |
| 227535 | Hereditary breast cancer | Disease | 10 |
| 1331 | Familial prostate cancer | Disease | 15 |
| 440437 | Familial colorectal cancer Type X | Disease | 10 |
| 52416 | Mantle cell lymphoma | Disease | 3 |
| 67038 | B-cell chronic lymphocytic leukemia | Disease | 10 |
Phenotype Associations (HPO)
Total Phenotypes: 138
TOP 50 Clinical Phenotypes:
| HPO ID | Phenotype |
|---|
| HP:0001251 | Ataxia |
| HP:0002073 | Progressive cerebellar ataxia |
| HP:0000524 | Conjunctival telangiectasia |
| HP:0000252 | Microcephaly |
| HP:0002721 | Immunodeficiency |
| HP:0002720 | Decreased circulating IgA concentration |
| HP:0004315 | Decreased circulating IgG concentration |
| HP:0001888 | Decreased total lymphocyte count |
| HP:0005403 | Decreased total T cell count |
| HP:0005374 | Cellular immunodeficiency |
| HP:0002205 | Recurrent respiratory infections |
| HP:0002110 | Bronchiectasis |
| HP:0001909 | Leukemia |
| HP:0006721 | Acute lymphoblastic leukemia |
| HP:0002665 | Lymphoma |
| HP:0003002 | Breast carcinoma |
| HP:0002664 | Neoplasm |
| HP:0000819 | Diabetes mellitus |
| HP:0001952 | Glucose intolerance |
| HP:0003220 | Abnormality of chromosome stability |
| HP:0000639 | Nystagmus |
| HP:0001260 | Dysarthria |
| HP:0001350 | Slurred speech |
| HP:0002080 | Intention tremor |
| HP:0001337 | Tremor |
| HP:0001332 | Dystonia |
| HP:0001266 | Choreoathetosis |
| HP:0002075 | Dysdiadochokinesis |
| HP:0002167 | Abnormal speech pattern |
| HP:0004322 | Short stature |
| HP:0001508 | Failure to thrive |
| HP:0000823 | Delayed puberty |
| HP:0000134 | Female hypogonadism |
| HP:0000035 | Abnormal testis morphology |
| HP:0007495 | Prematurely aged appearance |
| HP:0002216 | Premature graying of hair |
| HP:0000778 | Hypoplasia of the thymus |
| HP:0006254 | Elevated alpha-fetoprotein |
| HP:0002910 | Elevated hepatic transaminase |
| HP:0000957 | Cafe-au-lait spot |
| HP:0001288 | Gait disturbance |
| HP:0002540 | Inability to walk |
| HP:0001315 | Reduced tendon reflexes |
| HP:0003202 | Skeletal muscle atrophy |
| HP:0002861 | Melanoma |
| HP:0006725 | Pancreatic adenocarcinoma |
| HP:0002894 | Neoplasm of the pancreas |
| HP:0002893 | Pituitary adenoma |
| HP:0001402 | Hepatocellular carcinoma |
| HP:0003006 | Neuroblastoma |
GWAS Associations
Total GWAS Signals: 33
| Study ID | Trait | P-value | Mapped Gene |
|---|
| GCST010304 | Cutaneous malignant melanoma | 2.0e-21 | ATM |
| GCST010303 | Nevus count or melanoma | 4.0e-21 | ATM |
| GCST90002381 | Eosinophil count | 3.0e-29 | ATM |
| GCST90002382 | Eosinophil percentage | 8.0e-21 | ATM |
| GCST010002 | Refractive error | 4.0e-19 | C11orf65 |
| GCST004624 | Sum eosinophil basophil counts | 6.0e-14 | ATM |
| GCST004606 | Eosinophil count | 3.0e-13 | ATM |
| GCST006462 | Uterine fibroids | 3.0e-12 | ATM |
| GCST005996 | Red blood cell count | 1.0e-11 | ATM |
| GCST008366 | Leukocyte telomere length | 7.0e-12 | C11orf65 |
| GCST007505 | Nevus count or melanoma | 8.0e-11 | C11orf65, ATM |
| GCST90000032 | Myeloproliferative neoplasms | 2.0e-10 | ATM |
| GCST90002388 | Lymphocyte count | 6.0e-10 | C11orf65, ATM |
| GCST000927 | Response to metformin (T2D) | 3.0e-09 | C11orf65 |
| GCST001267 | Melanoma | 3.0e-09 | ATM |
| GCST004710 | Renal cell carcinoma | 9.0e-09 | ATM |
| GCST006085 | Prostate cancer | 8.0e-09 | ATM |
| GCST004600 | Eosinophil percentage | 6.0e-09 | ATM |
| GCST009856 | Leukocyte telomere length | 1.0e-08 | ATM |
| GCST002318 | Rheumatoid arthritis | 1.0e-08 | - |
SUMMARY STATISTICS
| Category | Count |
|---|
| Ensembl Transcripts | 64 |
| RefSeq Entries | 109 |
| CCDS IDs | 2 |
| Exons (canonical) | 63 |
| Protein Length | 3,056 aa |
| PDB Structures | 14 |
| InterPro Domains | 11 |
| ClinVar Variants | 18,209 |
| SpliceAI Predictions | 11,573 |
| AlphaMissense Predictions | 20,248 |
| Reactome Pathways | 61 |
| GO Terms | 123 |
| STRING Interactions | 6,446 |
| IntAct Interactions | 264 |
| GWAS Associations | 33 |
| HPO Phenotypes | 138 |
| Orphanet Diseases | 8 |
| GenCC Disease Associations | 11 |
| ChEMBL Molecules Tested | 3,752 |
| Expression Datasets (SC) | 8 |
| Model Organism Orthologs | 3 |
| Human Paralogs | 5 |
Data Sources: HGNC, Ensembl, NCBI, UniProt, PDB, AlphaFold, ClinVar, SpliceAI, AlphaMissense, Reactome, Gene Ontology, STRING, IntAct, BioGRID, SIGNOR, CollecTRI, ChEMBL, PharmGKB, Bgee, Expression
Atlas, GenCC, Orphanet, HPO, GWAS Catalog
I've compiled a comprehensive cross-database identifier and functional mapping reference for human ATM (Ataxia Telangiectasia Mutated). This document covers all 12 requested sections with data
aggregated from over 20 biological databases.
Key highlights:
- Gene: HGNC:795 / ENSG00000149311 / Entrez 472 / OMIM 607585 on chromosome 11q22.3
- Protein: Q13315, 3,056 amino acids, a PI3K-related kinase critical for DNA damage response
- Structures: 14 PDB entries, with best resolution 2.5 Å (Cryo-EM)
- Clinical: 18,209 ClinVar variants; definitively linked to Ataxia-telangiectasia (AR) and hereditary breast cancer (AD)
- Pathways: Central to DNA double-strand break repair, p53 signaling, and cell cycle checkpoints
- Interactions: 6,446+ protein interactions; key partners include BRCA1, CHEK2, TP53, NBN
- Expression: Ubiquitously expressed across 286 tissues/cell types
- Pharmacology: VIP gene in PharmGKB; targeted by investigational ATM inhibitors in cancer trials